Trade TransMedics Group Inc - TMDX CFD
Add to favourite- Summary
- Historical Data
Spread | 0.28 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024818% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002596% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 0.7 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 82.94 |
Open | 84.59 |
1-Year Change | 98.75% |
Day's Range | 83.23 - 86.75 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Nov 5, 2024 | 82.94 | -1.51 | -1.79% | 84.45 | 84.72 | 82.55 |
Nov 4, 2024 | 84.83 | 3.07 | 3.75% | 81.76 | 85.19 | 81.56 |
Nov 1, 2024 | 82.35 | -0.27 | -0.33% | 82.62 | 85.37 | 80.78 |
Oct 31, 2024 | 81.89 | 0.39 | 0.48% | 81.50 | 82.87 | 79.84 |
Oct 30, 2024 | 81.89 | -5.82 | -6.64% | 87.71 | 87.82 | 81.45 |
Oct 29, 2024 | 88.45 | -2.66 | -2.92% | 91.11 | 96.15 | 85.43 |
Oct 28, 2024 | 126.13 | -3.02 | -2.34% | 129.15 | 133.95 | 126.05 |
Oct 25, 2024 | 125.09 | 1.64 | 1.33% | 123.45 | 126.43 | 120.67 |
Oct 24, 2024 | 121.92 | 1.45 | 1.20% | 120.47 | 123.43 | 118.95 |
Oct 23, 2024 | 118.55 | -3.52 | -2.88% | 122.07 | 122.95 | 116.53 |
Oct 22, 2024 | 122.89 | -1.16 | -0.94% | 124.05 | 125.83 | 121.56 |
Oct 21, 2024 | 124.35 | -2.20 | -1.74% | 126.55 | 127.63 | 121.81 |
Oct 18, 2024 | 126.51 | -0.68 | -0.53% | 127.19 | 131.65 | 126.46 |
Oct 17, 2024 | 127.08 | -3.00 | -2.31% | 130.08 | 131.70 | 125.75 |
Oct 16, 2024 | 129.84 | -1.31 | -1.00% | 131.15 | 131.99 | 126.15 |
Oct 15, 2024 | 131.70 | -3.38 | -2.50% | 135.08 | 135.58 | 131.15 |
Oct 14, 2024 | 134.13 | -1.82 | -1.34% | 135.95 | 135.95 | 133.45 |
Oct 11, 2024 | 135.08 | 0.03 | 0.02% | 135.05 | 137.27 | 134.85 |
Oct 10, 2024 | 135.70 | -0.25 | -0.18% | 135.95 | 135.95 | 133.32 |
Oct 9, 2024 | 137.11 | -1.34 | -0.97% | 138.45 | 139.04 | 134.83 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
TransMedics Group, Inc. Company profile
About TransMedics Group Inc
TransMedics Group, Inc. is a commercial-stage medical technology company. It is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. The Company has designed and developed organ care system (OCS) a portable organ perfusion, optimization and monitoring system that utilizes customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It has developed three OCS products, one for each of lung, heart and liver transplantations. Its OCS clinical programs include OCS Heart EXPAND Trial, OCS Heart EXPAND Continued Access Protocol, or CAP, Trial and OCS Heart PROCEED II Trials. Its organ care system (OCS) technology platform to perfuse donor organs with warm, oxygenated, nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, TransMedics Group Inc revenues increased 18% to $30.3M. Net loss increased 54% to $44.2M. Revenues reflect OCS Lung net revenue segment increase of 72% to $10.7M, OCS Heart net revenue segment increase of 25% to $17.7M, United States segment increase of 14% to $21.9M, All other countries segment increase of 31% to $8.4M.
Industry: | Advanced Medical Equipment & Technology (NEC) |
200 Minuteman Road
ANDOVER
MASSACHUSETTS 01810
US
News
FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024US elections: Trump leads the polls, but tariff talk spooks investors
As the US elections get closer we look at how Trump’s tariff plans could affect markets.
15:02, 22 October 2024Gold markets to trade
Last week, we explored the basic fundamental and technical approaches to gold trading. Having covered the key price drivers of this critical asset and how you might use data to trade it, you’re ready to assess the conditions for entry. But there are a range of markets that can effectively give you exposure to gold.
08:00, 21 October 2024US earnings seasons off to a solid start as focus shifts to tech giants
The US earnings season has started on a positive note, with major banks exceeding expectations and boosting market sentiment.Key themes for the sector include investments in artificial intelligence, capital expenditure returns, and consumer trends in advertising and e-commerce. The S&P 500 continues to climb, driven by strong earnings, resilient economic growth, and the potential for interest rate cuts. Keep an eye on significant support and resistance levels as the market tests new record highs.
14:31, 17 October 2024ECB Preview: cooling growth and inflation call for another rate cut
Markets are convinced the European Central Bank (ECB) will cut rates by 25 basis points again at Thursday’s meeting.
12:41, 16 October 2024Australian labour force data forecast to reveal stable jobs market
Australia's labour market remained stable in September 2024, with the unemployment rate forecast to hold at 4.2%, supported by a 25,200 person rise in employment. Despite the economy teetering on the edge of recession, strong hiring trends persist, challenging market economists' predictions.
07:41, 15 October 2024People also watch
Still looking for a broker you can trust?
Join the 650,000+ traders worldwide that chose to trade with Capital.com